![Brigette Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Brigette Roberts
Amministratore Delegato presso
IRULYA THERAPEUTICS INC.
Patrimonio netto: - $ in data 30/09/2026
Profilo
Dr. Brigette M.
Roberts, MD, is a Chief Executive Officer & Director at IRulya Therapeutics, Inc. and a Chief Executive Officer & Director at OrphAI Therapeutics, Inc. She is on the Board of Directors at IRulya Therapeutics, Inc. and OrphAI Therapeutics, Inc. Dr. Roberts was previously employed as a Principal by Nomura Securities International, Inc., a Founder by YYC Capital Management LLC, a Principal by Third Point Management Co. LLC, a Principal by Sturzas Institutional Research, Inc., and an Associate by Thomas Weisel Partners LLC.
She also served on the board at Ligand Pharmaceuticals, Inc. She received her undergraduate degree from Harvard University and a doctorate degree from New York University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/05/2026 | 0 ( -.--% ) | - $ | 30/09/2026 |
Posizioni attive di Brigette Roberts
| Società | Posizione | Inizio |
|---|---|---|
| IRULYA THERAPEUTICS INC. | Amministratore Delegato | 08/10/2026 |
AI Therapeutics, Inc.
 AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Amministratore Delegato | 01/02/2021 |
Precedenti posizioni note di Brigette Roberts
| Società | Posizione | Fine |
|---|---|---|
Nomura Securities International, Inc.
 Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/12/2012 |
YYC Capital Management LLC
 YYC Capital Management LLC Investment ManagersFinance YYC Capital Management manages a long/short equity hedge fund | Fondatore | 01/01/2012 |
Third Point Management Co. LLC
 Third Point Management Co. LLC Investment ManagersFinance Third Point Management Co. employs an event driven, value-oriented investment approach. Though not limited by sector, the firm tends to invest in the stocks of companies in the energy minerals, industrial services, finance and electronic technology sectors. They invest across all market-caps with most of their investments made in companies located in the US, Europe and Latin America. Third Point Management's research is based on a combination of bottom-up and top-down analysis that seeks to identify undervalued stocks. | Gestore di Portafoglio-Azioni | - |
| LIGAND PHARMACEUTICALS INCORPORATED | Direttore/Membro del Consiglio | 01/03/2007 |
Sturzas Institutional Research, Inc.
 Sturzas Institutional Research, Inc. Investment Banks/BrokersFinance Provides investment research | Corporate Officer/Principal | 01/01/2003 |
Formazione di Brigette Roberts
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
96
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Ligand Pharmaceuticals, Inc.
 Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Third Point Management Co. LLC
Third Point Management Co. LLC Investment ManagersFinance Third Point Management Co. employs an event driven, value-oriented investment approach. Though not limited by sector, the firm tends to invest in the stocks of companies in the energy minerals, industrial services, finance and electronic technology sectors. They invest across all market-caps with most of their investments made in companies located in the US, Europe and Latin America. Third Point Management's research is based on a combination of bottom-up and top-down analysis that seeks to identify undervalued stocks. | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Regional BanksFinance Operates as an investment banking firm | Finance |
Nomura Securities International, Inc.
Nomura Securities International, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sturzas Institutional Research, Inc.
Sturzas Institutional Research, Inc. Investment Banks/BrokersFinance Provides investment research | Finance |
YYC Capital Management LLC
YYC Capital Management LLC Investment ManagersFinance YYC Capital Management manages a long/short equity hedge fund | Finance |
Quince Therapeutics, Inc.
 Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
AI Therapeutics, Inc.
AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing therapies for pulmonary diseases | Health Technology |
